|Bid||0.00 x 900|
|Ask||0.00 x 1800|
|Day's range||58.32 - 58.96|
|52-week range||46.48 - 64.94|
|Beta (5Y monthly)||0.21|
|PE ratio (TTM)||38.77|
|Forward dividend & yield||1.40 (2.38%)|
|Ex-dividend date||25 Feb 2021|
|1y target est||63.60|
The Institute for Antiracism in Medicine Co-Founder & The University of Illinois College of Medicine Assistant Professor of Clinical & Family Medicine Dr. Brittani James joins Yahoo Finance Live to discuss the latest updates amid the COVID-19 pandemic.
The PRAC of the European Medicines Agency (EMA) has advised against giving AstraZeneca's (AZN) Vaxzevria COVID-19 vaccine to people with a history of capillary leak syndrome, a rare blood disorder.
The EMA considers the vaccine safe for all age groups, and has been clear in its advice that the benefits of taking the vaccine outweigh the risks, however some member states have restricted its use in the older population.